Stephane BOGEN,David DUKHAN,Guillaume BRANDT,Claire Pierra ROUVIERE,Cyril B. DOUSSON,Francois-Rene ALEXANDRE
申请号：
US16311363
公开号：
US20190233463A1
申请日:
2017.06.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to Cyclic Phosphate Substituted Nucleoside Compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein in A, B, R1, R2, R3, Q and V are as defined herein. The present invention also relates to compositions comprising a Cyclic Phosphate Substituted Nucleoside Compound, and methods of using the Cyclic Phosphate Substituted Nucleoside Compounds for treating or preventing HCV infection in a patient.
